Davis Hugh M.
SEC insider (Form 3/4/5 filer). CIK 0002045027. President and COO at Aclaris Therapeutics, Inc. (ACRS). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in WAYNE, PA.
Companies Davis Hugh M. has filed insider reports for
- Aclaris Therapeutics, Inc. (ACRS): Director, Officer, President and COO
Davis Hugh M.
CIK: 0002045027
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aclaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 3, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect18.7K shares- - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
336.3K shares- - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
96.1K shares- - Dec 2, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect26.8K shares- - Feb 3, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
261.6K shares- - Feb 3, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
74.7K shares- - Dec 2, 2024ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
375K shares- - Dec 2, 2024ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
107K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 3, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 18,675 | - | $0 | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 336,300 | - | - | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 96,100 | - | - | Direct |
| Dec 2, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 26,750 | - | - | Direct |
| Feb 3, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 261,600 | - | - | Direct |
| Feb 3, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 74,700 | - | - | Direct |
| Dec 2, 2024 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 375,000 | - | - | Direct |
| Dec 2, 2024 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 107,000 | - | - | Direct |
1-8 of 8 transactions